Skip to content
value.today

Solarea Bio, Inc.

Total raised
$37 M
4 rounds on record
Latest round
$10 M
Nov 2025
First round on record
Aug 2020
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Solarea Bio, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Nov 2025$10 MNo. 4$2 to $10 million

Solarea Bio, Inc.: Raise no. 4, Nov 2025

Investors in this round

5 investors had bought by the notice of Nov 20, 2025: 5 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$10 M (amount offered: indefinite)
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Catherine Balsam-Schwaber · Executive Officer, Director
  • Eric Schott · Executive Officer
  • Anula Jayasuriya · Director
  • Gregory Sieczkiewicz · Director
  • Matthew Walker · Director
  • Neal Bhadkamkar · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Eric Schott, Chief operating officer. Source: SEC Form D, newest notice filed Nov 20, 2025. Read the notice at the SEC.

equitySEC
Aug 2024$1 MNo. 3Under $2 million

Solarea Bio, Inc.: Raise no. 3, Aug 2024

Investors in this round

1 investor had bought by the notice of Sep 10, 2024: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M (amount offered: indefinite)
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Eric Schott · Executive Officer
  • Gerardo Toledo · Executive Officer, Director
  • Ilissa Larimore · Executive Officer
  • Anula Jayasuriya · Director
  • Gregory Sieczkiewicz · Director
  • Matthew Walker · Director
  • Neal Bhadkamkar · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Gerardo Toledo, Chief executive officer. Source: SEC Form D, newest notice filed Sep 10, 2024. Read the notice at the SEC.

equitySEC
May 2023$15 MNo. 2$10 to $50 million

Solarea Bio, Inc.: Raise no. 2, May 2023

Investors in this round

4 investors had bought by the notice of May 9, 2023: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$15 M of $25 M offered; $10 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Eric Schott · Executive Officer
  • Gerardo Toledo · Executive Officer, Director
  • Anula Jayasuriya · Director
  • Gregory Sieczkiewicz · Director
  • Matthew Walker · Director
  • Neal Bhadkamkar · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Gerardo Toledo, Chief executive officer. Source: SEC Form D, newest notice filed May 9, 2023. Read the notice at the SEC.

equitySEC
Aug 2020$11 MNo. 1$10 to $50 million

Solarea Bio, Inc.: Raise no. 1, Aug 2020

Investors in this round

15 investors had bought by the notice of Sep 11, 2020: 15 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$11 M of $15 M offered; $4 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Eric Schott · Executive Officer
  • Gerardo Toledo · Executive Officer, Director
  • Anula Jayasuriya · Director
  • Gregory Sieczkiewicz · Director
  • Matthew Walker · Director
  • Neal Bhadkamkar · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Gerardo Toledo, Chief executive officer. Source: SEC Form D, newest notice filed Sep 11, 2020. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Solarea Bio, Inc. chose not to state its revenue in its newest notice of a funding round (Nov 2025).

    SEC Form D · Nov 2025

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Nov 2025

That is all the official record says: Solarea Bio, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Solarea Bio, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 15 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Solarea Bio, Inc.
NameRoleNamed in
Catherine Balsam-SchwaberExecutive officerNov 2025
Eric SchottExecutive officerNov 2025
Gerardo ToledoExecutive officerSep 2024
Ilissa LarimoreExecutive officerSep 2024
Anula JayasuriyaDirectorNov 2025
Catherine Balsam-SchwaberDirectorNov 2025
Gregory SieczkiewiczDirectorNov 2025
Matthew WalkerDirectorNov 2025
Neal BhadkamkarDirectorNov 2025
Gerardo ToledoDirectorSep 2024